DBV Technologies SA (DBVT)
0.7831
+0.02
(+2.88%)
USD |
NASDAQ |
Nov 04, 16:00
0.7831
0.00 (0.00%)
After-Hours: 20:00
DBV Technologies Max Drawdown (5Y): 97.67% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 97.67% |
| September 30, 2024 | 97.67% |
| August 31, 2024 | 97.67% |
| July 31, 2024 | 97.67% |
| June 30, 2024 | 97.67% |
| May 31, 2024 | 97.67% |
| April 30, 2024 | 97.67% |
| March 31, 2024 | 97.67% |
| February 29, 2024 | 97.67% |
| January 31, 2024 | 97.67% |
| December 31, 2023 | 97.67% |
| November 30, 2023 | 97.67% |
| October 31, 2023 | 97.67% |
| September 30, 2023 | 97.67% |
| August 31, 2023 | 97.67% |
| July 31, 2023 | 97.67% |
| June 30, 2023 | 97.67% |
| May 31, 2023 | 97.67% |
| April 30, 2023 | 97.67% |
| March 31, 2023 | 97.67% |
| February 28, 2023 | 97.67% |
| January 31, 2023 | 97.67% |
| December 31, 2022 | 97.67% |
| November 30, 2022 | 97.67% |
| October 31, 2022 | 97.67% |
| Date | Value |
|---|---|
| September 30, 2022 | 97.67% |
| August 31, 2022 | 97.67% |
| July 31, 2022 | 97.67% |
| June 30, 2022 | 97.67% |
| May 31, 2022 | 97.67% |
| April 30, 2022 | 97.53% |
| March 31, 2022 | 97.53% |
| February 28, 2022 | 97.37% |
| January 31, 2022 | 97.20% |
| December 31, 2021 | 97.20% |
| November 30, 2021 | 97.20% |
| October 31, 2021 | 97.20% |
| September 30, 2021 | 97.20% |
| August 31, 2021 | 97.20% |
| July 31, 2021 | 97.20% |
| June 30, 2021 | 97.20% |
| May 31, 2021 | 97.20% |
| April 30, 2021 | 97.20% |
| March 31, 2021 | 97.20% |
| February 28, 2021 | 97.20% |
| January 31, 2021 | 97.20% |
| December 31, 2020 | 97.20% |
| November 30, 2020 | 97.20% |
| October 31, 2020 | 97.20% |
| September 30, 2020 | 96.80% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
88.35%
Minimum
Nov 2019
97.67%
Maximum
May 2022
96.67%
Average
97.60%
Median
Max Drawdown (5Y) Benchmarks
| Edap TMS SA | 80.70% |
| Genfit SA | 88.42% |
| Cellectis SA | 97.08% |
| Adaptimmune Therapeutics PLC | 96.45% |
| Akari Therapeutics PLC | 98.58% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -54.99 |
| Beta (5Y) | 0.6584 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 93.12% |
| Historical Sharpe Ratio (5Y) | -0.4993 |
| Historical Sortino (5Y) | -1.032 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 41.16% |